| Type | Private |
|---|---|
| Industry | Clinical research organizations Pharmaceutical |
| Founded | 2021 |
| Headquarters | Durham, North Carolina, U.S. |
Number of locations | 12+ facilities in 10+ countries |
Key people | CEO:Gavin Nichols |
| Services | Medical Imaging |
| Revenue |  $82 million (2022)[1][2] |
Number of employees | 2000-5000[3] |
| Website | calyx |
CALYX formerly Parexel Informatics business[4] is a spin off from Parexel International.[1][5] Calyx is an American provider of biopharmaceutical services.[6] In January 2021 Following the strategic separation of the Parexel Informatics business from Parexel International, a spin-off, Calyx AI, a provider of medical imaging, eClinical and regulatory solutions and services to solve complex challenges in clinical research, is launched as an independent company.[7]
References
- 1 2 "Merck and Veeva Ink 10-Year Partnership Agreement". BioPharm International.
- ↑ "Calyx Partnership with Top 5 CRO Extended through 2024". finance.yahoo.com.
- ↑ "Company".
- ↑ https://www.clinicalresearchnewsonline.com/news/2022/06/10/calyx-named-medical-imaging-provider-by-clinscience
- ↑ "Calyx Spins Out of Parexel". Applied Clinical Trials Online.
- ↑ "Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services".
- ↑ "Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services". Retrieved 29 March 2023.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.